Relmada Therapeutics, Inc. (RLMD) Advances Oncology and CNS Therapies with Promising Phase 2 Data
Relmada Therapeutics, Inc. (NASDAQ:RLMD) is a clinical-stage biotech company that develops innovative therapies for oncology and central nervous system disorders.